EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Glial cell transcriptome analyses in 3xTg-AD mice: Effects of aging, disease progression, and anti-Aβ immunotherapy

Doris Lambracht-Washington, Min Fu, Navid Manouchehri, Linda S Hynan, Olaf Stuve, Roger N Rosenberg

Aging Brain · 2023 · 3 · 100066

DOI: 10.1016/j.nbas.2023.100066 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging Brain, 2023. Verfasst von Doris Lambracht-Washington und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, UT Southwestern Medical Center Dallas, USA. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To investigate how changes in expression of glial genes relate to a progression of Alzheimer's disease (AD) pathology, and how anti-Aβ immunotherapy impact these changes, we conducted a transcriptomic analysis for brains from cohorts of 2-, 10-, and 20 month old 3xTg-AD mice, and a cross-sectional study in groups of 20 month-old mice treated with active DNA Aβ42 immunization, passive immunotherapy, untreated, and wild-type (wt) controls.

Methods

Twenty-four Formalin-Fixed Paraffin-Embedded (FFPE) mouse brain sections were used for the gene expression analyses (nanostring). Adjacent sections from these and additional mouse brains were stained for microglia using antibodies detecting IbaI and Gal3. For a semi-quantitative analysis of increased tau and amyloid pathology with aging and disease progression, a comparison of ELISA results from brains of 12 and 20 months old 3xTg-AD mice were shown.

Results

Based on the different comparisons of transcript numbers found the 3xTg-AD age groups with the senescent 20 months old wt control mouse brains, and the 20 months old 3xTg-AD mouse brains with the 20 months old wt control mouse brains, genes were assigned as upregulated due to aging, or due to disease progression, or due to both. The immunohistochemistry of microglia markers revealed that Gal3 might be an important marker for phagocytosing microglia around amyloid plaques. The comparison of the two anti-Aβ immunotherapy approaches showed a differential downregulation of inflammatory glial genes.

Conclusion

These results are relevant for future clinical trials using active anti-amyloid immunotherapy.

Schlagwörter

Stichwörter der Autor:innen

AD mouse modelsAgingAlzheimer's diseaseBrain transcriptomeGlia activationImmunotherapyNeurodegeneration

Autor:innen und Institutionen

  • Department of Neurology, UT Southwestern Medical Center Dallas, USA.
  • Departments of Population and Data Sciences (Biostatistics) & Psychiatry, UT Southwestern Medical Center Dallas, USA.
  • VA North Texas Health Care System, VA Medical Center Dallas, USA.

Förderung

  • NIA NIH HHS
  • National Institutes of Health

Zitieren

APA

Lambracht-Washington, D., Fu, M., Manouchehri, N., Hynan, L. S., Stuve, O., & Rosenberg, R. N. (2023). Glial cell transcriptome analyses in 3xTg-AD mice: Effects of aging, disease progression, and anti-Aβ immunotherapy. Aging Brain, 3, 100066. https://doi.org/10.1016/j.nbas.2023.100066

Vancouver

Lambracht-Washington D, Fu M, Manouchehri N, Hynan LS, Stuve O, Rosenberg RN. Glial cell transcriptome analyses in 3xTg-AD mice: Effects of aging, disease progression, and anti-Aβ immunotherapy. Aging Brain. 2023;3:100066. doi:10.1016/j.nbas.2023.100066

BibTeX
@article{LambrachtWashington2023,
  author = {Lambracht-Washington, Doris and Fu, Min and Manouchehri, Navid and Hynan, Linda S and Stuve, Olaf and Rosenberg, Roger N},
  title = {Glial cell transcriptome analyses in 3xTg-AD mice: Effects of aging, disease progression, and anti-Aβ immunotherapy},
  journal = {Aging Brain},
  year = {2023},
  volume = {3},
  pages = {100066},
  doi = {10.1016/j.nbas.2023.100066}
}
Kostenlos starten →